| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |